Skip to main content
logo
TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
4.380
+0.050 (1.15%)
Jul 29, 2026, 4:00 PM EDT - Market closed

TriSalus Life Sciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
44.8845.1529.4318.5112.4-
Revenue Growth
39.64%53.41%58.99%49.31%--
Gross Profit
38.1838.1925.3315.9110.14-
Operating Income
-28.03-26.95-36.17-54.48-36.44-3.04
Net Income
-58.49-69.69-33.23-63.6-50.02-4.77
Earnings Per Share
-1.41-1.84-1.31-6.77-161.55-131.65
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
56.5520.448.5311.789.41250.21
Total Debt
34.7934.8224.141.61.960.54
Net Cash (Debt)
21.77-14.39-15.6110.187.45249.66
Net Cash Growth
---36.65%-97.02%-0.67%
Net Cash Per Share
0.50-0.38-0.621.0824.071139.50

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-19.99-18.01-40.84-50.58-32.31-1.74
Capital Expenditures
-0.31-0.92-0.35-0.59-0.66-
Free Cash Flow
-20.3-18.93-41.19-51.17-32.97-1.74
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
85.07%84.57%86.06%85.93%81.79%-
Operating Margin
-62.45%-59.68%-122.88%-294.28%-293.91%-
Pretax Margin
-60.84%-86.86%-102.07%-320.64%-380.53%-
Profit Margin
24.09%-86.88%-102.09%-320.69%-380.60%-
FCF Margin
-45.22%-41.93%-139.95%-276.41%-265.91%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
5.997.735.3212.066.64-